{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:40:09Z","timestamp":1767973209208,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016016","name":"Gilead UK and Ireland Corporate Contributions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["MR_UU_12023"],"award-info":[{"award-number":["MR_UU_12023"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02532"],"award-info":[{"award-number":["2018-02532"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["681712"],"award-info":[{"award-number":["681712"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000864","name":"British HIV Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L00528X\/1"],"award-info":[{"award-number":["MR\/L00528X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virus Eradication"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jve.2021.100056","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T11:54:03Z","timestamp":1631620443000},"page":"100056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2256-423X","authenticated-orcid":false,"given":"Jasmini","family":"Alagaratnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Toombs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Heslegrave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Gissl\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Pett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-2035","authenticated-orcid":false,"given":"Amanda","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nneka","family":"Nwokolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Kopycinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Dorrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Kinloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5703-3984","authenticated-orcid":false,"given":"Matthew","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Frater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Winston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jve.2021.100056_bib1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","article-title":"Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy","volume":"28","author":"May","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jve.2021.100056_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jve.2021.100056_bib3","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.med.53.082901.104024","article-title":"The challenge of viral reservoirs in HIV-1 infection","author":"Blankson","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jve.2021.100056_bib4","doi-asserted-by":"crossref","first-page":"19479","DOI":"10.7448\/IAS.17.4.19479","article-title":"Towards an HIV cure","volume":"17","author":"Deeks","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jve.2021.100056_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","author":"Davey","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jve.2021.100056_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2012.08.010","article-title":"Redefining the viral reservoirs that prevent HIV-1 eradication","author":"Eisele","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jve.2021.100056_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","author":"Finzi","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jve.2021.100056_bib8","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1073\/pnas.0804192105","article-title":"HIV rebounds from latently infected cells, rather than from continuing low-level replication","volume":"105","author":"Joos","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jve.2021.100056_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2055-6640(20)30275-2","article-title":"Establishment of latent HIV-1 reservoirs: what do we really know?","author":"Vanhamel","year":"2019","journal-title":"J Virus Erad"},{"key":"10.1016\/j.jve.2021.100056_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jve.2021.100056_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jve.2021.100056_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/v11030269","article-title":"Cat and mouse: HIV transcription in latency, immune evasion and cure\/remission strategies","author":"Delannoy","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jve.2021.100056_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro2223","article-title":"Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs","author":"Coiras","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jve.2021.100056_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11904-011-0108-2","article-title":"HIV reservoirs and strategies for eradication","volume":"9","author":"Smith","year":"2012","journal-title":"Curr HIV AIDS Rep"},{"key":"10.1016\/j.jve.2021.100056_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s13365-014-0271-5","article-title":"HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research","author":"Churchill","year":"2015","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jve.2021.100056_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S2055-6640(20)30489-1","article-title":"CNS reservoirs for HIV: implications for eradication","volume":"1","author":"Hellmuth","year":"2015","journal-title":"J Virus Erad"},{"key":"10.1016\/j.jve.2021.100056_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s13365-014-0287-x","article-title":"HIV-1 target cells in the CNS","author":"Joseph","year":"2015","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jve.2021.100056_bib18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jve.2021.100056_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw618","article-title":"Proviral latency, persistent human immunodeficiency virus infection, and the development of latency reversing agents","author":"Margolis","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jve.2021.100056_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \u201ckill\u201d into \u201cshock and kill\u201d: strategies to eliminate latent HIV","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jve.2021.100056_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/13550280590952817","article-title":"Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells","author":"Danaher","year":"2005","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jve.2021.100056_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000001430","article-title":"HIV cure strategies: response to ignore the central nervous system at your patients peril","author":"Winston","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jve.2021.100056_bib23","article-title":"Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells","volume":"1\u20139","author":"Gray","year":"2016","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jve.2021.100056_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2005.11.014","article-title":"HIV tat and neurotoxicity","author":"King","year":"2006","journal-title":"Microb Infect"},{"key":"10.1016\/j.jve.2021.100056_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/QAD.0b013e3283437d2f","article-title":"Eradication of HIV from the brain: reasons for pause","volume":"25","author":"Nath","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jve.2021.100056_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000002264","article-title":"Perspective on potential impact of HIV central nervous system latency on eradication","author":"Chan","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.jve.2021.100056_bib27","doi-asserted-by":"crossref","first-page":"ofv037","DOI":"10.1093\/ofid\/ofv037","article-title":"Activation of latent HIV by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the CNS","volume":"2","author":"Rasmussen","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jve.2021.100056_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000001267","article-title":"Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques","author":"Gama","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jve.2021.100056_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jve.2021.100056_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jve.2021.100056_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jve.2021.100056_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116081","article-title":"Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection","author":"Peterson","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jve.2021.100056_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14737159.2017.1341313","article-title":"Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls","volume":"17","author":"Yilmaz","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jve.2021.100056_bib34","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00415-006-0481-8","article-title":"CSF neurofilament protein (NFL) - a marker of active HIV-related neurodegeneration","volume":"254","author":"Abdulle","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.jve.2021.100056_bib35","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1212\/WNL.0000000000003107","article-title":"CSF neurofilament light","volume":"87","author":"Khalil","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jve.2021.100056_bib36","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jve.2021.100056_bib37","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.84.10.3472","article-title":"Neurofilament gene expression: a major determinant of axonal caliber","volume":"84","author":"Hoffman","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jve.2021.100056_bib38","article-title":"Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study","author":"Gissl\u00e9n","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jve.2021.100056_bib39","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000271","article-title":"Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS","author":"Bergman","year":"2016","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.jve.2021.100056_bib40","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","author":"Novakova","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jve.2021.100056_bib41","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jve.2021.100056_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.325","article-title":"Neurofilament light chain: a biomarker for genetic frontotemporal dementia","author":"Meeter","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jve.2021.100056_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2021-000143","article-title":"Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis","volume":"3","author":"Alagaratnam","year":"2021","journal-title":"BMJ Neurol Open"},{"key":"10.1016\/j.jve.2021.100056_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)32990-3","article-title":"Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial","author":"Fidler","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jve.2021.100056_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000984","article-title":"Design and pre-clinical evaluation of a universal HIV-1 vaccine","author":"L\u00e9tourneau","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.jve.2021.100056_bib46","series-title":"THE IMPACT of VORINOSTAT and THERAPEUTIC VACCINE on GUT HIV DNA: THE RIVER GUT STUDY - CROI Conference","author":"Thornhill","year":"2019"},{"key":"10.1016\/j.jve.2021.100056_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)32990-3","article-title":"Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial","author":"Fidler","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jve.2021.100056_bib48","volume":"vols. 1\u20132","author":"Sheet","year":"2017"},{"key":"10.1016\/j.jve.2021.100056_bib49","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03821","article-title":"HIV-1 DNA predicts disease progression and post-treatment virological control","volume":"3","author":"Williams","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.jve.2021.100056_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03175","article-title":"A novel vaccine strategy employing serologically different chimpanzee adenoviral vectors for the prevention of HIV-1 and HCV coinfection","author":"Hartnell","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jve.2021.100056_bib51","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jve.2021.100056_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.50972","article-title":"Confounding effect of blood volume and body mass index on blood neurofilament light chain levels","author":"Manouchehrinia","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jve.2021.100056_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jit311","article-title":"Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size","author":"Jain","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jve.2021.100056_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz030","article-title":"Very early initiation of antiretroviral therapy during acute HIV infection is associated with normalized levels of immune activation markers in cerebrospinal fluid but not in plasma","author":"Hellmuth","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jve.2021.100056_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz031","article-title":"Antiretroviral treatment of acute HIV infection normalizes levels of cerebrospinal fluid markers of central nervous system (CNS) inflammation: a consequence of a reduced CNS reservoir?","author":"Gissl\u00e9n","year":"2019","journal-title":"J Infect Dis"}],"container-title":["Journal of Virus Eradication"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664021000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664021000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:11:40Z","timestamp":1761855100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2055664021000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2055664021000297"],"URL":"https:\/\/doi.org\/10.1016\/j.jve.2021.100056","relation":{},"ISSN":["2055-6640"],"issn-type":[{"value":"2055-6640","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Virus Eradication","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jve.2021.100056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100056"}}